FIELD: chemistry.
SUBSTANCE: use of compounds of formula (I): where: X denotes >CR1R2 or, when R6 denotes H, X denotes >SO2; Y denotes >CR1R2; Z denotes >C=O, >CH2, single bond; R1 denotes H, R2 denotes H, -COOH, -OH; or R1 and R2 together denote =O, ethylenedioxy or hydroxyimino group; R3 denotes H, lower alkyl group; R4 denotes two H, =O, hydroxyimino group; R5 denotes H, lower alkyl group, halogen; R6 denotes H, lower alkoxy, COOH; R7 and R8 are identical or different from each other and each denotes H, lower alkyl, halogen; and pharmaceutically acceptable salts thereof and esters for preparing a medicinal agent.
EFFECT: agent having neuroprotective action against hypoxia.
2 tbl, 24 ex, 13 cl
Title | Year | Author | Number |
---|---|---|---|
IMIDAZOPYRIDINE COMPOUND | 2005 |
|
RU2373206C2 |
INDOLOPYRROLOCARBAZOLE DERIVATIVES OF SUGARS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND METHOD OF INHIBITION OF TUMOR PROLIFERATION | 1997 |
|
RU2167880C2 |
TRIAZOLE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND ANTIFUNGAL COMPOSITION | 1996 |
|
RU2146250C1 |
THIENOPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2142275C1 |
HETEROCYCLIC COMPOUND | 2006 |
|
RU2382781C2 |
THERAPEUTIC PREPARATION AND PREVENTIVE PREPARATION FOR TREATING ALZHEIMER'S DISEASE | 2011 |
|
RU2560171C2 |
THERAPEUTIC AGENT OR PREVENTIVE AGENT FOR TREATING URINE COLLECTION DISORDER | 2011 |
|
RU2559318C2 |
THERAPEUTIC PREPARATION OR PREVENTIVE PREPARATION FOR TREATING FIBROMYALGIA | 2011 |
|
RU2560168C2 |
BICYCLIC GAMMA AMINO ACID DERIVATIVE | 2008 |
|
RU2446148C2 |
N-HYDROXYLUREAS AS ANTI-INFLAMMATORY AGENTS | 1995 |
|
RU2152935C2 |
Authors
Dates
2010-11-27—Published
2006-02-02—Filed